European Pharmaceutical Review

OCTOBER 31, 2024

Announcement of the UK Government’s 2024 Autumn Budget on 30 October marks the first Labour budget in 14 years. It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

PM360

OCTOBER 22, 2024

Measuring medical affairs is key to driving clinical innovation, engaging scientific communities, and improving patient outcomes. To justify investment in medical affairs, it’s important to demonstrate impact and align stakeholders with different priorities. Measuring medical affairs success is challenging. References: 1.[link]

Medical 52

Medical Medical science Healthcare Healthcare 52

PM360

APRIL 22, 2024

Medical science Liaisons know that change is coming; How are they cashing in? Medical science liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.

Education 52

Education Medical Medical science Customer Relationship Management 52

European Pharmaceutical Review

DECEMBER 28, 2023

Following their introduction, these therapies have moved to early lines of treatment, but unfortunately, a significant number of patients are not cured with these approaches. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84

PM360

MARCH 22, 2024

Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact.

Medical 52

Medical Education Sales Medical science 52

Clarivate

JUNE 21, 2024

While the exponential growth of publications in the field of medical science presents a challenge for human reviewers, AL/ML algorithms can excel here as they do not suffer from fatigue while dealing with such large data sets. However, we are also deliberately adopting a cautious approach (Cochrane, 2024).”

Training 81

Training Government Medical science Ethics 81

Pharmaceutical Technology

NOVEMBER 3, 2022

According to the agency, shortages of both drugs are expected to last until 2024, as a result of growing demand. These] are life-saving medications. And patients can die when we do not have these readily available,” he says. Here, the long-term shortages can be attributed to two factors, says Page.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111